Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.8.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenue $ 4,400 $ 11,695 $ 14,092 $ 40,283
Cost of goods sold 17,783 17,233 33,875 41,862
Gross deficit (13,383) (5,538) (19,783) (1,579)
Operating expenses:        
Research and development 17,639 16,071 81,242 57,772
Sales and marketing 3,301 22,705 17,606 94,219
General and administrative 260,605 471,944 698,602 798,717
Total operating expenses 281,545 510,720 797,450 950,708
Operating loss (294,928) (516,258) (817,233) (952,287)
Interest expense (493,829) (1,176,014) (1,458,665) (1,523,026)
Other income (expense) (1) (4,010)
Financing cost (350,000) (350,000)
Change in fair value of warrant liability (163,891) 171,184
Change in fair value of derivative liabilities (18,961) (2,577,655) 535,535 (2,577,655)
Net loss $ (971,609) $ (4,619,928) $ (1,569,179) $ (5,406,978)
Net loss per share- basic and diluted (in dollars per share) $ (0.02) $ (0.10) $ (0.03) $ (0.13)
Weighted average shares outstanding basic and diluted (in shares) 48,336,915 45,107,792 47,557,779 42,615,867